Antigua and Barbuda - Import of Heparin for Therapeutic Use
Since 2013, Antigua and Barbuda Import of Heparin for Therapeutic Use was down by 40% year on year. With $1,439.22 in 2018, the country was number 134 comparing other countries in Import of Heparin for Therapeutic Use. Antigua and Barbuda is overtaken by Sri Lanka, which was ranked number 133 with $1,443.46 and is followed by Cabo Verde with $1,222.39. France topped the ranking with $960,128,653.6 in 2019, that is a decrease of 6.6% compared to 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize witnessed the best average annual growth at +183.7% per year, while Mauritania recorded the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2018 | 1,439.22 |
| 2017 | 900.68 |
| 2016 | |
| 2015 | 834.00 |
| 2014 | 19,755.00 |
Download all data from 1999 to 2018
How does Antigua and Barbuda rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 133 |
#133
Sri Lanka
|
1,443.46 | 2019 | -58.1 % | -23.1 % | View data | |
| 134 |
#134
Antigua and Barbuda
|
1,439.22 | 2018 | +59.8 % | -40.0 % | View data | |
| 135 |
#135
Cabo Verde
|
1,222.39 | 2019 | +117.8 % | -36.2 % | View data | |